Profile of usage of a reference diagnostic service on oral pathology: a 10-year evaluation by Karla Rachel Oliveira e Silva et al.
Oliveira e Silva et al. BMC Health Services Research 2014, 14:653
http://www.biomedcentral.com/1472-6963/14/653RESEARCH ARTICLE Open AccessProfile of usage of a reference diagnostic service
on oral pathology: a 10-year evaluation
Karla Rachel Oliveira e Silva1, Ana Lu?sa Lara Siqueira 1, Patr?cia Carlos Caldeira 1*,
Mauro Henrique Nogueira Guimar?es de Abreu 2 and Maria C?ssia Ferreira de Aguiar 1Abstract
Background: Despite the professional and academic relevance of the Brazilian oral pathology diagnostic laboratories,
no information about their usage profile is available in the English literature. The objective of the present study is to
report data about the histopathological and immunohistochemical exams performed in a Brazilian regional reference
laboratory of oral pathology, as well as its main users.
Methods: Information about all histopathological exams performed between 2002 and 2012 was retrieved from the
files of the Oral and Maxillofacial Pathology Service of the School of Dentistry of Universidade Federal de Minas Gerais.
Data collected included: 1) requestor of exam; 2) diagnosis classification; and 3) immunohistochemical tests. Descriptive
statistical analyses were done.
Results: 13,522 histopathological exams were performed, mean 1,229/year. The Public Health System of the city of
Belo Horizonte was the main requestor of exams (77.13%), followed by private professionals (19.26%), and other
cities (2.03%). Most lesions were considered benign (12,599/ 93.17%), with 854 malignant lesions (6.32%). 469
immunohistochemical tests were performed; 324 (69.08%) were from benign diagnosis, and 145 (30.92%) from
malignant diagnosis. The most used antibodies were against S100, vimentin, smooth muscle actin, actin muscle
specific HHF-35, and pan-cytokeratin AE1/AE3.
Conclusions: Public Health System is the major user of the diagnostic service on oral pathology in our institution.
Most diagnoses were of benign lesions, although many malignant lesions were detected. Immunohistochemistry
was particularly important in solving challenging cases.
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The most important Dental Schools in Brazil maintain
oral pathology diagnostic laboratories, as occur in other
countries [1]. At the Universidade Federal de Minas
Gerais, which is the main public University of the State,
and one of the most important Universities in Brazil, the
Service of Oral and Maxillofacial Pathology was first
established in 1966. From 1994 on, it is organized the
way it is today. The laboratory? s main work is to perform
histopathological and cytological exams of lesions affecting
oral and maxillofacial tissues. Several health services send
materials for analyses. Some of them comprise the Public* Correspondence: pat_caldeira@yahoo.com.br
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article, unless otherwise stated.Health System (PHS) of the city of Belo Horizonte, which
includes all the dental clinics of the School of Dentistry
of the Universidade Federal de Minas Gerais, the Clinics
Hospital of the same University, the Odilon Behrens
Municipal Hospital, among others. Another source for
the specimens are the dental clinics of the PHS of other
cities within the Minas Gerais State. Finally, private pro-
fessionals also request exams. The oral pathologists work-
ing in the laboratory are professors at the School, and they
are also coordinators of the service. They are licensed as
specialists by the Regional Council of Dentistry and are
fellows of the Brazilian Society of Oral Stomatology and
Pathology (SOBEP). Master and doctorate students par-
ticipate in the diagnostic process as well.
As stated before [1], providing such a service, the oral
pathology service accomplishes four goals: to provide aentral. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Table 1 Exams, requestors, diagnosis, and immunohistochemical tests performed in the laboratory from 2002 to 2012
Year Requestors of the exams Total Diagnoses classification Immunohistochemical
testsPublic Health system of the
city of Belo Horizonte
Private Public Health system
of other cities
Indeterminate Benign Malignant Indeterminate
n % n % n % n % n % n % n % n % n %* %**
2002 1,161 77.71 253 16.93 22 1.47 58 3.88 1,494 11.05 1,426 95.45 67 4.48 1 0.07 1 0.21 0.07
2003 980 79.22 107 8.65 97 7.84 53 4.28 1,237 9.15 1,167 94.34 64 5.17 6 0.49 28 5.97 2.26
2004 983 83.16 145 12.27 39 3.30 15 1.27 1,182 8.74 1,118 94.59 62 5.25 2 0.17 59 12.58 4.99
2005 1,025 83.40 165 13.43 9 0.73 30 2.44 1,229 9.09 1,158 94.22 71 5.78 0 0.00 28 5.97 2.28
2006 1,020 84.23 169 13.96 2 0.17 20 1.65 1,211 8.96 1,134 93.64 67 5.53 10 0.83 21 4.48 1.73
2007 854 86.61 118 11.97 3 0.30 11 1.12 986 7.29 894 90.67 68 6.90 24 2.43 44 9.38 4.46
2008 1,030 81.68 228 18.08 1 0.08 2 0.16 1,261 9.33 1,168 92.62 87 6.90 6 0.48 15 3.20 1.19
2009 925 71.32 339 26.14 18 1.39 15 1.16 1,297 9.59 1,232 94.99 65 5.01 0 0.00 75 15.99 5.78
2010 958 66.07 455 31.38 34 2.34 3 0.21 1,450 10.72 1,327 91.52 121 8.34 2 0.14 62 13.22 4.28
2011 809 70.47 318 27.70 20 1.74 1 0.09 1,148 8.49 1,058 92.16 87 7.58 3 0.26 68 14.50 5.92
2012 685 66.70 307 29.89 30 2.92 5 0.49 1,027 7.60 917 89.29 95 9.25 15 1.46 68 14.50 6.62
Total 10,430 77.13 2,604 19.26 275 2.03 213 1.58 13,522 100.00 12,599 93.17 854 6.32 69 0.51 469 100.00 3.47
%* = percentage of immunohistochemical tests per total of immunohistochemical tests performed over 10 years.
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http://www.biomedcentral.com/1472-6963/14/653diagnostic laboratory for the licensed practitioner and
dental students; to obtain material that can be used for
teaching purposes; to help training new oral patholo-
gists; and to provide a source of research material.
Despite the professional and academic relevance of the
Brazilian oral pathology diagnostic laboratories, no infor-
mation about their user ? s profile is available in the English
literature, as there is for some services worldwide [1-5].
Thus, the aim of the present study was to investigate the
profile of usage of an oral pathology diagnostic center over
a 10-year period. We report data about the histopatho-
logical and immunohistochemical exams, as well as the
main users of this regional reference laboratory. The
findings reported herein should be relevant to compare
with international reports. Moreover, the coordinators
of the service can look for better strategies to improve
the coverage of the service. Finally, we hope to contrib-
ute to the improvement of the oral pathology and oral
medicine visibility among dentists, general pathologists,
and medical staff.
Methods
This retrospective study was performed at the Oral and
Maxillofacial Pathology Service of the School of Dentistry
of Universidade Federal de Minas Gerais. This is the Oral
Pathology reference center in the state of Minas Gerais,
which capital is the city of Belo Horizonte. Information
about all histopathological exams performed between
2002 and 2012 was retrieved from the electronic files of
the Service. These electronic files contain a database cre-
ated within Microsoft Access software in 1997 and contain
all biopsy records of the service since 2002.
Data collected for the study were saved into a database
and included: 1) requestor of exam (PHS of Belo Horizonte;
PHS of other cities in the State of Minas Gerais; or pri-
vate professionals); 2) diagnosis classification (benign
or malignant lesion); 3) immunohistochemical tests (per-
















































Figure 1 Requestors of the exams over 10 years ? absolute number.statistical analyses were done. No confidence intervals
were calculated because this study is a census. The study
was submitted to the Committee of Ethics in Research of
the Universidade Federal de Minas Gerais (protocol num-
ber 30318914.2.0000.5149) and is in compliance with
the Helsinki Declaration.
Results
Over the 10 years, 13,522 histopathological exams were
performed (Table 1). The mean number of exams in a
year was 1,229. Most exams (1,494/11.05%) were done
in 2002, followed by 2010 (1,450/10.72%) (Figure 1). The
fewest number of exams was done in 2007 (986/7.29%),
followed by 2012 (1,027/7.60%) (Figure 1).
The PHS of Belo Horizonte was the main requestor of
exams in all years, accounting for 77.13% of the total of
exams over the 10 years (ranging from 66.07% to 86.61%)
(Table 1, Figures 1 and 2). The PHS of other cities re-
quested 2.03% of exams (ranging from 0.09% to 4.28%,
Table 1, Figures 1 and 2). Private professionals sent
19.26% of exams over 10 years (ranging from 8.65% to
31.38%) (Table 1, Figures 1 and 2).
Most lesions were considered benign (12,599/93.17%),
with 854 malignant lesions (6.32%), and 69 (0.51%) inde-
terminate diagnoses. In 2010, we had the highest number
of malignant lesions (121/8.34%); nevertheless, it was in
2012 that these lesions represented the highest percentage
of diagnosis (95/9.25%) (Table 1). Of interest, the percent-
age of malignant lesions diagnosed in specimens sent by
the PHS of Belo Horizonte (6.91%) was slightly higher
than the mean, followed by requests from PHS of other
cities (4.49%), and private professionals (5.09%) (Table 2).
An indeterminate diagnosis was mostly established for
lesions from PHS of other cities (1.09%), followed by
PHS of Belo Horizonte (0.41%) and private practitioners
(0.19%) (Table 2).
In total, 469 immunohistochemical tests were performed,
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Figure 2 Requestors of the exams over 10 years - percentage.
Oliveira e Silva et al. BMC Health Services Research 2014, 14:653 Page 4 of 7
http://www.biomedcentral.com/1472-6963/14/653the whole period, 324 (69.08%) immunohistochemical tests
were from benign diagnoses, and 145 (30.92%) from ma-
lignant diagnoses. Most immunohistochemical tests 369
(78.68%) were performed in specimens sent by the PHS of
Belo Horizonte, followed by 98 (20.89%) from private pro-
fessionals, and 2 (0.43%) from PHS of other cities.
Forty-five different antibodies were used in immuno-
histochemical tests (Table 3). The most used ones were
against S100 (65/13.86%), vimentin (51/10.87%), smooth
muscle actin (34/7.24%), actin muscle specific HHF-35
(31/6.60%), and AE1/AE3 (28/5.97%). Figure 4 shows the
types of antibodies used, grouped according to their
specificity.
Discussion
The present study reports the profile of usage of a reference
oral and maxillofacial pathology laboratory along 10 years.
It is noticeable that the PHS of the city of Belo Horizonte
accounted for most specimens sent to the laboratory all
over the years. This System encompasses some Institutions,




Public Health System of Belo Horizonte 9,666 92.67 72
Private professionals 2,482 95.31 11
Public Health System from other cities 258 93.82 14
Indeterminate 193 90.61 2
Total 12,599 93.17 85located. It should be taken into account that the Health
Institutions linked to this System provide a free dental
care in oral medicine and oral pathology, and many spe-
cialists in these areas work in those Institutions. This
probably explains the high percentage of biopsies from
PHS found in the study. Of relevance, some authors have
already reported that general dentists usually refer the pa-
tients needing oral pathology evaluation and biopsy to a
specialist [5]. This can be taking place in Belo Horizonte
city as well, contributing for the centralization of dental
care in oral pathology and oral medicine at the reference
Institutions, i.e. the ones from the PHS.
Interestingly, along the 10 years, and especially from
2008 on, we could observe an increase in the specimens
sent by private practitioners. In their 30-year retrospective,
Franklin and Jones [3] also reported a fourfold increase in
number of specimens received from general dentistry prac-
titioners. This augmentation should be due to some factors.
First, more specialists in Stomatology, oral pathology, and
oral medicine should be working in their private offices,
performing the biopsies in their own offices. Thus, a lowerrs
alignant Indeterminate Total
n n
1 6.91 43 0.41 10,430 77.13
7 4.49 5 0.19 2,604 19.26
5.09 3 1.09 275 2.03
0.94 18 8.45 213 1.58



















































































Figure 3 Absolute number of immunohistochemical tests and diagnoses of benign and malignant lesions. The main axis refers to
? immunohistochemistry? and ? malignant lesions? values. The secondary axis refers to ? benign lesions? values.
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http://www.biomedcentral.com/1472-6963/14/653number of professionals are referring patients to the public
health institutions to perform those procedures. Second,
maybe general dentists are becoming more confident to
perform oral biopsies in their daily practice [5]. Third,
maybe private practitioners used to send their speci-
mens to general pathology services, instead of to anTable 3 Specificity and amount of the immunohistochemical
tests performed over 10 years
Antigen Number of tests*
S100 65
Vimentin 51
Smooth muscle actin 34









Epithelial membrane antigen, Plasmacell 7
P53, Leucocyte common antigen, CD1a, Glut-1, CD99 5
CD45RO, Lambda, Kappa, CD10, CD5 4




Laminin, Tryptase, c-ERB2, Calponin, Androgen,
CK20, CD30, Factor 13a, CD57, Caldesmon
1
Indeterminate 8
*antibodies with the same number of tests are grouped.oral pathology laboratory [2]. Along the years, the high
quality work offered by the oral pathology service
helped private practitioners to know and trust the ser-
vice, thus they could send their specimens to us. Oral
pathologists are more capable in diagnosing pathologic
conditions which are more specific of their area of
work, like salivary glands lesions and odontogenic tumors
[2,6]. Interestingly, despite some dentists still refer to gen-
eral pathologists, Barret and Speight [6] found that most
(97.6%) general pathologists were aware of oral patholo-
gists in United Kingdom, and 91.6% perceived a need for
them.
Of relevance, when private practitioners send exams to
our laboratory, a fee is charged for the service, while
when the PHS is the requestor of the exam, no fee is ap-
plied and the services are subsidized by the government.
Concerning this, Chugh et al. [2] reported that at the
oral pathology diagnostic service of Faculty of Dentistry
in Toronto, more than 90% of the specimens were from
private practitioners, but there was a decrease of 31% in
the number of specimens sent to the laboratory after the
removal of a subsidy.
Malignant lesions comprised 6.32% of the lesions diag-
nosed over 10 years in the present study. It is interesting
to observe that the percentage was similar among the
three requestors. Nevertheless, considering the absolute
number, the great majority of malignant lesions were from
PHS. These data have an important epidemiological and
financial impact for the PHS, which is responsible for of-
fering the complete treatment for those patients. Apart of
this, malignant lesions accounted for a median of 1.38% of
diagnoses in the 4-year retrospective study reported by
Chugh et al. [2]. Franklin and Jones [3] reported a 30-year
retrospective study of specimens sent by general dental



















Figure 4 Antibodies? specificity used in immunohistochemistry.
Oliveira e Silva et al. BMC Health Services Research 2014, 14:653 Page 6 of 7
http://www.biomedcentral.com/1472-6963/14/653during the year evaluated by Wan e Savage [5], all the 26
cases of malignancies received by their laboratory were
from specialists. These findings seem to indicate that
general dentists usually refer patients with suspicion of
a malignant lesion for specialists [3].
Our data reveal that immunohistochemistry was applied
in 3.47% of cases, either malignant or benign. This tool
was important to establish diagnoses of malignant salivary
gland neoplasms, mesenchymal lesions and others. The
most useful markers were S100, vimentin, smooth muscle
actin, actin muscle specific, and pan-cytokeratin. These
antigens accounted for 44.6% of all reactions. This profile
can help other laboratories to select which antibodies they
should have to start an immunohistochemical service for
diagnostic proposals.
At the Oral and Maxillofacial Pathology Service, immu-
nohistochemistry has been an important tool in reaching
the diagnosis of malignant salivary gland tumors. Diagno-
ses of those tumors are challenging given the histological
overlap among various subtypes and their morphologic
heterogeneity [7]. This fact also explains the most employed
antibodies used in the service, markers to luminal (low-
molecular weight cytokeratins), abluminal and myoepithe-
lial cells (high-molecular cytokeratins), and against myoid
proteins, besides other driven specifically to myoepithelial
cells (Figure 4).Moreover, the vast majority of diagnoses could be
performed within the microscopic evaluation of routinely
stained material only. Instead, immunohistochemistry
should be useful to confirm diagnostic hypothesis in some
cases, helping to identify some rare or atypical benign le-
sions, or to characterize malignant tumors [8]. Both situa-
tions are exemplified in our service with diagnoses of
lesions such as solitary fibrous tumor [9] and lymphomas
[10] (Figure 4).
Conclusions
The present study is the first one in English literature to re-
port an evaluation of the profile of usage of a Brazilian oral
pathology service. The Public Health System of the city of
Belo Horizonte is responsible for the majority of exams.
An increase in the number of exams from particular practi-
tioners was observed. Most diagnoses performed over
10 years were benign, although many malignant lesions
were detected as well. Immunohistochemistry proved to be
useful in some cases, either malignant or benign. S100,
vimentin, smooth muscle actin, actin muscle specific, and
pan-cytokeratin antigens were the most used ones.
This study emphasizes that it is indispensable to
submit every tissue removed from the oral cavity and
maxillofacial apparatus to histopathological analysis. This
reflects an increasing need for oral pathology services.
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http://www.biomedcentral.com/1472-6963/14/653Studies on this issue should be encouraged to contribute
to the improvement of the oral pathology and oral medi-
cine visibility, among dentists, general pathologists, or
medical staff.
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